1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

CEO on IND status for VGX-100 Open Briefing with CEO & MD Robert Klupacs … – 4-traders (press release)

November 15, 2011Transplant Rejectionadmin

CEO on IND status for VGX-100 Open Briefing with CEO & MD Robert Klupacs ...
4-traders (press release)
However, we recognise that dry eye disease is one of the most difficult corneal diseases to develop a treatment for, so we're also working on treatments for two niche front-of-the-eye conditions: corneal allograft rejection post corneal transplant; ...

Post navigation

← Celebs speak up for organ donation – The Asian Age Study stirs debate over transplants for alcoholics – Alexandria Town Talk →

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos